SYNTHESIS OF NEW 2(1H) QUINOLONE ANTICONVULSANT DRUGS
Award amount
$99,991Program and phase
STTR · Phase IAward year
1998Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Synthonics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- FAHCUXEPEU49
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Proof of Extended Absorption of Liothyronine from PolyZincLiothyronine (PZL) inHumans
- Poly Metallo Liothyronine Complexes for Hypothyroidism Treatment
- Levodopa Pharmacokinetic Optimization by Metal Coordination
- Levodopa Pharmacokinetic Optimization by Metal Coordination
- Levodopa Pharmokinetic Optimization by Metal Coordination
Research funding history
6 SBIR/STTR records share this UEI (1998–2019). Reported award amounts total $6,860,426. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services